Format

Send to

Choose Destination
Neurosurgery. 2012 Mar;70(3):634-8. doi: 10.1227/NEU.0b013e3182320d1a.

Neurocognitive impairment in adults with moyamoya disease without stroke.

Author information

1
Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California 94305-5235, USA.

Abstract

BACKGROUND:

Adults with moyamoya disease (MMD) have been shown to manifest cognitive impairment, but it is unclear whether this is the result of ischemic stroke.

OBJECTIVE:

To determine whether adults with MMD but without stroke have cognitive impairment.

METHODS:

We performed detailed neuropsychological assessments in 30 adults with angiographically confirmed MMD without magnetic resonance imaging (MRI) evidence of stroke.

RESULTS:

Twenty patients (67%) exhibited small T2 hyperintensities in the cerebral subcortical white matter on brain MRI but no evidence of gray matter damage. Significant cognitive impairment, defined as half of test scores ≥ 1 SD below the normal mean, was present in 7 patients (23%). Executive functioning, mental efficiency, and word finding were the ability areas most frequently impaired, whereas memory was relatively intact. Clinically significant emotional distress (depression and/or anxiety) was present in 11 patients (37%). Comparable cognitive findings were also observed in the subset of 10 patients (33%) with completely normal static brain MRI.

CONCLUSION:

Cognitive impairment in MMD can occur in the absence of ischemic stroke as manifested on MRI.

PMID:
21849919
DOI:
10.1227/NEU.0b013e3182320d1a
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center